IDEAYA Biosciences, Inc. (IDYA)
USD 20.93
(2.25%)
USD 20.93
(2.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -115.22 Million | -87.17 Million | -55.77 Million | 55.46 Million | -39.31 Million | -27.62 Million |
| Net Income | -112.96 Million | -58.65 Million | -49.76 Million | -34.49 Million | -41.97 Million | -34.34 Million |
| Depreciation & Amortization | 4 Million | 2.1 Million | 1.72 Million | 1.38 Million | 1.24 Million | 886 Thousand |
| Deferred income taxes | -124.51 Million | - | - | - | - | -873 Thousand |
| Stock-based compensation | 18.48 Million | 11.62 Million | 8.23 Million | 3.6 Million | 2.16 Million | 950 Thousand |
| Change in working capital | -13.2 Million | -41.55 Million | -17.81 Million | 84.4 Million | -284 Thousand | 1.65 Million |
| Other non-cash items | 112.96 Million | -695 Thousand | 1.83 Million | 562 Thousand | -467 Thousand | 4.1 Million |
| Investing Cash Flow | -158.45 Million | -33.4 Million | -69.66 Million | -146.24 Million | 2.26 Million | -63.17 Million |
| Investments in PPE | -2.36 Million | -3.44 Million | -2.64 Million | -493 Thousand | -1.35 Million | -1.7 Million |
| Acquisitions | 156.08 Million | 33.4 Million | 67.02 Million | -18 Thousand | -8000.00 | - |
| Investment purchases | -595.98 Million | -255.8 Million | -314.99 Million | -242.31 Million | -88 Million | -133.3 Million |
| Sales/Maturities of investments | 439.89 Million | 225.84 Million | 247.97 Million | 96.56 Million | 91.62 Million | 71.83 Million |
| Other Investing Activities | -156.08 Million | -33.4 Million | -67.02 Million | 18 Thousand | 8000.00 | -61.47 Million |
| Financing Cash Flow | 362.71 Million | 97.16 Million | 145.45 Million | 128.75 Million | 50.61 Million | 105.37 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 309.76 Million | 97.16 Million | 145.45 Million | 127.23 Million | 50.32 Million | 105.37 Million |
| Other Financing Activities | 52.95 Million | 97.16 Million | 145.45 Million | 1.51 Million | 289 Thousand | 105.37 Million |
| Accounts receivables | 193 Thousand | 892 Thousand | 774 Thousand | -1.87 Million | - | - |
| Accounts payables | 2.63 Million | 1.86 Million | 1.16 Million | 225 Thousand | -195 Thousand | 322 Thousand |
| Inventory | -2.28 Million | - | 3.78 Million | 2.28 Million | - | - |
| Other working capital | -13.75 Million | -44.31 Million | -23.54 Million | 83.77 Million | -89 Thousand | 1.33 Million |
| Cash at beginning of period | 68.63 Million | 92.15 Million | 72.14 Million | 34.17 Million | 20.61 Million | 6.03 Million |
| Cash at end of period | 157.77 Million | 68.73 Million | 92.15 Million | 72.14 Million | 34.17 Million | 20.61 Million |
| Capital Expenditure | -2.36 Million | -3.44 Million | -2.64 Million | -493 Thousand | -1.35 Million | -1.7 Million |
| Effect of forex changes on cash | 106 Thousand | - | - | - | - | - |
| Net cash flow / Change in cash | 89.14 Million | -23.41 Million | 20 Million | 37.97 Million | 13.56 Million | 14.57 Million |
| Free Cash Flow | -117.59 Million | -90.61 Million | -58.42 Million | 54.97 Million | -40.66 Million | -29.32 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -51.82 Million | -52.77 Million | -39.57 Million | -33.95 Million | -112.96 Million | -27.44 Million |
| Depreciation & Amortization | -18.68 Million | 1.09 Million | 1.08 Million | 1.02 Million | 4 Million | 1.02 Million |
| Deferred income taxes | - | - | - | -37.83 Million | -124.51 Million | - |
| Stock-based compensation | 9.21 Million | 9.73 Million | 6.31 Million | 4.79 Million | 18.48 Million | 5.3 Million |
| Change in working capital | -10.37 Million | 15.69 Million | -5.32 Million | 8.26 Million | -13.2 Million | -5.49 Million |
| Other non-cash items | 22.43 Million | -4.42 Million | 2.61 Million | 33.95 Million | 112.96 Million | -3.56 Million |
| Investing Cash Flow | -20.03 Million | 68.55 Million | -353.97 Million | -111.94 Million | -158.45 Million | 51.34 Million |
| Investments in PPE | -457 Thousand | -973 Thousand | -1.32 Million | -838 Thousand | -2.36 Million | -603 Thousand |
| Acquisitions | - | - | - | 111.1 Million | 156.08 Million | -51.95 Million |
| Investment purchases | -213.72 Million | -164.76 Million | -475.78 Million | -221.6 Million | -595.98 Million | -81.83 Million |
| Sales/Maturities of investments | 194.14 Million | 234.29 Million | 123.13 Million | 110.5 Million | 439.89 Million | 133.78 Million |
| Other Investing Activities | - | 69.53 Million | -352.64 Million | -111.1 Million | -156.08 Million | 51.95 Million |
| Financing Cash Flow | 286.5 Million | 39.18 Million | 349.11 Million | 140.89 Million | 362.71 Million | 27.83 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 9.4 Million | - | - | - | - | - |
| Common Stock Issuance | -108.14 Million | 39.18 Million | 343.65 Million | 127.41 Million | 309.76 Million | 25.97 Million |
| Other Financing Activities | 385.24 Million | 39.18 Million | 5.46 Million | 13.47 Million | 52.95 Million | 1.85 Million |
| Accounts receivables | -19 Thousand | 14 Thousand | 3000.00 | 6.68 Million | 193 Thousand | -6.54 Million |
| Accounts payables | -3.93 Million | 9.69 Million | -453 Thousand | 1.74 Million | 2.63 Million | -699 Thousand |
| Inventory | - | - | - | 4.05 Million | -2.28 Million | 3.12 Million |
| Other working capital | -1.11 Million | 5.98 Million | -4.87 Million | -4.22 Million | -13.75 Million | -1.37 Million |
| Cash at beginning of period | 183.04 Million | 108.34 Million | 157.77 Million | 151.85 Million | 68.63 Million | 103.56 Million |
| Cash at end of period | 401.19 Million | 183.04 Million | 109.1 Million | 157.77 Million | 157.77 Million | 152.57 Million |
| Capital Expenditure | -457 Thousand | -973 Thousand | -1.32 Million | -838 Thousand | -2.36 Million | -603 Thousand |
| Effect of forex changes on cash | - | - | - | 722 Thousand | 106 Thousand | - |
| Net cash flow / Change in cash | 218.14 Million | 74.7 Million | -48.67 Million | 5.92 Million | 89.14 Million | 49 Million |
| Free Cash Flow | -49.69 Million | -33.85 Million | -45.13 Million | -24.58 Million | -117.59 Million | -30.77 Million |
CTMX
OMV
GRPOF
LMDCF
KALYANIFRG
5657